Muscle loss and muscle-made proteins in people with diabetes, obesity or hormone disorders
Looks at muscle loss and muscle-made proteins in adults with metabolic or hormone diseases.
Plain-language title generated from the registry record
Registry title: Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases
Key facts
- Where
- Woluwe-Saint-Pierre - Sint-Pieters-Woluwe, BelgiumSee the site
Where in Belgium
- Cliniques Universitaires Saint-LucWoluwe-Saint-Pierre - Sint-Pieters-Woluwe, BelgiumTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- Trial code
- NCT07703683
- Record updated
- 14 July 2026
- Original description
Prospective, observational, single-center, study evaluating the prevalence of sarcopenia / sarcopenic obesity in individuals with metabolic and / or endocrine diseases, as well as the potential role of myokines as biomarkers or drivers of sarcopenia / sarcopenic obesity in this population.Read full original descriptionShow less
Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases
Prospective, observational, single-center, study evaluating the prevalence of sarcopenia / sarcopenic obesity in individuals with metabolic and / or endocrine diseases, as well as the potential role of myokines as biomarkers or drivers of sarcopenia / sarcopenic obesity in this population.
.
Inclusion: Metabolic or endocrine disease.
Exclusion: Systemic steroid use (> 1 mg/kg hydrocortisone) or exogenous Cushing's syndrome; Psychological, family, sociological or geographical conditions that could potentially limit compliance with the study protocol; History of cancer within the five years prior to the study or Cushing's syndrome due to ACTH-secreting tumor; Known myopathy.